Donoghue Forlines’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.36M Buy
29,377
+5,049
+21% +$234K 0.39% 101
2025
Q1
$1.48M Sell
24,328
-3,473
-12% -$212K 0.47% 80
2024
Q4
$1.57M Buy
27,801
+10,106
+57% +$572K 0.53% 58
2024
Q3
$916K Buy
17,695
+949
+6% +$49.1K 0.26% 120
2024
Q2
$695K Buy
16,746
+2,262
+16% +$93.9K 0.2% 107
2024
Q1
$785K Buy
14,484
+3,892
+37% +$211K 0.22% 97
2023
Q4
$543K Sell
10,592
-11,474
-52% -$589K 0.17% 155
2023
Q3
$1.28M Buy
22,066
+6,071
+38% +$352K 0.46% 60
2023
Q2
$1.02M Buy
15,995
+3,256
+26% +$208K 0.32% 78
2023
Q1
$883K Sell
12,739
-22,421
-64% -$1.55M 0.32% 90
2022
Q4
$2.53M Buy
35,160
+20,143
+134% +$1.45M 0.89% 17
2022
Q3
$1.07M Sell
15,017
-22,638
-60% -$1.61M 0.39% 30
2022
Q2
$2.9M Sell
37,655
-7,548
-17% -$581K 0.76% 18
2022
Q1
$3.3M Buy
45,203
+21,557
+91% +$1.57M 0.72% 20
2021
Q4
$1.47M Sell
23,646
-17,093
-42% -$1.07M 0.25% 86
2021
Q3
$2.41M Sell
40,739
-683
-2% -$40.4K 0.47% 45
2021
Q2
$2.77M Sell
41,422
-340
-0.8% -$22.7K 0.52% 44
2021
Q1
$2.64M Buy
41,762
+18,198
+77% +$1.15M 0.51% 40
2020
Q4
$1.46M Buy
23,564
+3,467
+17% +$215K 0.28% 89
2020
Q3
$1.21M Buy
+20,097
New +$1.21M 0.33% 78
2020
Q2
Sell
-13,414
Closed -$748K 65
2020
Q1
$748K Sell
13,414
-37,944
-74% -$2.12M 0.17% 29
2019
Q4
$3.3M Sell
51,358
-37,345
-42% -$2.4M 0.51% 53
2019
Q3
$4.5M Sell
88,703
-54,870
-38% -$2.78M 0.64% 30
2019
Q2
$6.51M Buy
+143,573
New +$6.51M 0.76% 50